An update on pharmacologic management of chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine
Hetal J Patel

Abstract

Chronic obstructive pulmonary disease (COPD) is a widespread disease process with important clinical and economic implications. This review will summarize new pharmacotherapy for the treatment of COPD. Several recent clinical trials have led to the approval of new inhaler therapies for COPD. Many of these are specifically targeting combination long-acting β-agonists and long-acting muscarinic antagonists for late stage COPD. Several new bronchodilators are available on the market, especially in combination form. The new drug combinations have positive data though clinical relevance, and comparisons to available and well established therapies are still needed. Specifically, translating improved forced expiratory volume into meaningful clinical outcomes remains challenging.

References

Feb 24, 2001·American Journal of Respiratory and Critical Care Medicine·D CookM Sears
Jun 29, 2004·The European Respiratory Journal·B R CelliUNKNOWN ATS/ERS Task Force
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Oct 7, 2008·The New England Journal of Medicine·Donald P TashkinUNKNOWN UPLIFT Study Investigators
May 14, 2010·American Journal of Respiratory and Critical Care Medicine·James F DonohueUNKNOWN INHANCE Study Investigators
Aug 10, 2010·The European Respiratory Journal·O KornmannUNKNOWN INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-µg Doses with COPD Patients) study investigators
Apr 27, 2011·Respiratory Research·Paul W JonesEsther Garcia Gil
Aug 26, 2011·The New England Journal of Medicine·Richard K AlbertUNKNOWN COPD Clinical Research Network
Mar 24, 2012·The European Respiratory Journal·Paul W JonesEsther Garcia Gil
Aug 21, 2013·The European Respiratory Journal·Roopa TrivediAlison Church
Dec 19, 2013·Thorax·Tsung YuMilo A Puhan
May 9, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Debra J Reid, Alexa A Carlson
Jun 27, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Gary T FergusonPaul Sachs
Aug 6, 2014·Chest·Gustavo J Rodrigo, Vicente Plaza
Oct 15, 2014·Expert Review of Respiratory Medicine·Andrea SegretiMario Cazzola
Jan 13, 2015·The European Respiratory Journal·Roland BuhlEric Bateman
Sep 1, 2015·Respiratory Medicine·Dave SinghLeif Bjermer

❮ Previous
Next ❯

Citations

May 12, 2019·British Journal of Pharmacology·Loes E M KistemakerReinoud Gosens

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Clinical Trials Mentioned

NCT02296138

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.